Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Wenzel

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|March 31, 2022
Editorial Comment to Testicular cancer and YouTube: What do you expect from a social media platform?Mike Wenzel
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2024
Editorial Comment to: "Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity"Christoph Würnschimmel, Luca Afferi, Mike Wenzel
Current Opinion in Urology|December 15, 2018
Dusting, fragmenting, popcorning or dustmenting?Mike Wenzel, Matthew Bultitude, Johannes Salem
The Prostate|May 25, 2021
Reply to the letter to the editor: RE: Wenzel M, et al. The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. The Prostate. 2021;1-8Mike Wenzel, Christoph Würnschimmel, Pierre I Karakiewicz
European Urology|August 9, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol 2022;81:576-85Mike Wenzel, Felix K-H Chun, Andreas Becker
Der Pathologe|June 25, 2021
[Metastatic castration-resistant prostate cancer]Vanessa Henriques, Mike Wenzel, Melanie-Christin Demes, et al.
European Urology Open Science|October 6, 2022
Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still OutMike Wenzel, Benedikt Hoeh, Philipp Mandel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2025
Reply to "<sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?"Mike Wenzel, Daniel Groener, Felix K H Chun, et al.
Frontiers in Surgery|August 26, 2021
Management of Medium and Long Term Complications Following Prostate Cancer Treatment Resulting in Urinary Diversion - A Narrative ReviewBenedikt Hoeh, Stefan C Müller, Luis A Kluth, et al.
Urologie (Heidelberg, Germany)|February 10, 2023
[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer]Mike Wenzel, Benedikt Hoeh, Felix K H Chun, et al.
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
International Journal of Urology : Official Journal of the Japanese Urological Association|March 31, 2022
Editorial Comment to Testicular cancer and YouTube: What do you expect from a social media platform?Mike Wenzel
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2024
Editorial Comment to: "Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity"Christoph Würnschimmel, Luca Afferi, Mike Wenzel
Current Opinion in Urology|December 15, 2018
Dusting, fragmenting, popcorning or dustmenting?Mike Wenzel, Matthew Bultitude, Johannes Salem
The Prostate|May 25, 2021
Reply to the letter to the editor: RE: Wenzel M, et al. The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. The Prostate. 2021;1-8Mike Wenzel, Christoph Würnschimmel, Pierre I Karakiewicz
European Urology|August 9, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol 2022;81:576-85Mike Wenzel, Felix K-H Chun, Andreas Becker
Der Pathologe|June 25, 2021
[Metastatic castration-resistant prostate cancer]Vanessa Henriques, Mike Wenzel, Melanie-Christin Demes, et al.
European Urology Open Science|October 6, 2022
Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still OutMike Wenzel, Benedikt Hoeh, Philipp Mandel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2025
Reply to "<sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?"Mike Wenzel, Daniel Groener, Felix K H Chun, et al.
Frontiers in Surgery|August 26, 2021
Management of Medium and Long Term Complications Following Prostate Cancer Treatment Resulting in Urinary Diversion - A Narrative ReviewBenedikt Hoeh, Stefan C Müller, Luis A Kluth, et al.
Urologie (Heidelberg, Germany)|February 10, 2023
[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer]Mike Wenzel, Benedikt Hoeh, Felix K H Chun, et al.
Pageof 22